A novel reagent for the screening of haptoglobin‐deficient blood donors
Vox Sanguinis · 2023
DOI: 10.1111/vox.13543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2023. Verfasst von Naoko Watanabe-Okochi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Kanto-Koshinetsu Block Blood Center, Japanese Red Cross Society, Tokyo, Japan. Hauptthemen laut MEDLINE: Blood Donors, Haptoglobins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives In Japan, the prevalence of haptoglobin deficiency is approximately 1 in 4000. Haptoglobin‐deficient individuals may produce anti‐haptoglobin from allo‐immunization, leading to serious transfusion reactions. Therefore, implementation of a consistent supply of haptoglobin‐deficient fresh frozen plasma is crucial. We developed a novel reagent to facilitate large‐scale identification of haptoglobin‐deficient individuals as potential donors of plasma products. Materials and Methods We established mouse monoclonal anti‐haptoglobin‐producing cell lines (three clones) using the hybridoma method by immunizing mice with the haptoglobin protein. Purified antibodies were conjugated with carboxylate‐modified polystyrene latex beads and used for haptoglobin measurements by the latex agglutination method using an automatic analyser (LABOSPECT008). Samples with low protein concentrations were re‐examined by enzyme‐linked immunosorbent assay to confirm the results. Additionally, the haptoglobin gene was amplified by polymerase chain reaction to confirm the haptoglobin deletion allele ( Hp del ).
Results
From February to October 2022, 7476 blood donor samples were screened. Two haptoglobin‐deficient and 21 low‐haptoglobin‐expressing individuals were identified. Two haptoglobin‐deficient donors were found homozygous for Hp del , and 19 (90%) of the 21 low‐haptoglobin‐expressing individuals were heterozygous for Hp del , which includes the first reported case of heterozygous Hp del /Hp Johnson .
Conclusion
We developed a new reagent for the detection of haptoglobin deficiency, which is automatable and inexpensive and appears useful for large‐scale screening of blood donors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kanto-Koshinetsu Block Blood Center, Japanese Red Cross Society, Tokyo, Japan.
- Fujikura Kasei Co., Ltd, Tokyo, Japan.
- Central Blood Institute, Japanese Red Cross Society, Tokyo, Japan.
ORCID-Profile: Naoko Watanabe-Okochi, Nelson-Hirokazu Tsuno
Zitieren
APA
Watanabe-Okochi, N., Sato, A., Okuyama, A., Tomiyoshi, G., Suzuki, Y., Watanabe, Y., Kitsukawa, K., Anazawa, M., Shimoyamada, T., Takahashi, D., Onodera, T., Uchikawa, M., Tsuno, N. H., & Muroi, K. (2023). A novel reagent for the screening of haptoglobin‐deficient blood donors. Vox Sanguinis. https://doi.org/10.1111/vox.13543
Vancouver
Watanabe-Okochi N, Sato A, Okuyama A, Tomiyoshi G, Suzuki Y, Watanabe Y, et al. A novel reagent for the screening of haptoglobin‐deficient blood donors. Vox Sanguinis. 2023. doi:10.1111/vox.13543
BibTeX
@article{WatanabeOkochi2023,
author = {Watanabe-Okochi, Naoko and Sato, Ayaka and Okuyama, Akira and Tomiyoshi, Go and Suzuki, Yumi and Watanabe, Yukiko and Kitsukawa, Kaori and Anazawa, Masako and Shimoyamada, Takashige and Takahashi, Daisuke and Onodera, Takayuki and Uchikawa, Makoto and Tsuno, Nelson-Hirokazu and Muroi, Kazuo},
title = {A novel reagent for the screening of haptoglobin‐deficient blood donors},
journal = {Vox Sanguinis},
year = {2023},
doi = {10.1111/vox.13543}
}
EUVIMED